http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2170578-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_94ff2d78578d95d1e8d3a2233c76188d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-683 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 |
| filingDate | 1996-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2001-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32808cea118b941c552aac24ade63a55 |
| publicationDate | 2001-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2170578-C2 |
| titleOfInvention | Pharmaceutical composition containing n-chlorophenylcarbamates or n- chlorophenylthiocarbamates and derivatives of n-phospho-noglycine for inhibition of malignant neoplasms growth and viruses in mammals |
| abstract | FIELD: medicine, oncology, virology, pharmacy. SUBSTANCE: invention relates to pharmaceutical composition inhibiting the growth of malignant neoplasms and tumors in mammals and method of treatment of cancer patients and method of treatment of mammals with viral infections. Composition has a mixture containing N-chlorophenylcarbamates or N- chlorophenylthiocarbamates and derivatives of N-phosphono-glycine that are herbicides in the ratio from 10: 1 to 1:10. Composition kills or inhibits tumor growth effectively but it is safe for normal cells. EFFECT: enhanced antitumor and antiviral activity of composition. 19 cl, 2 tbl |
| priorityDate | 1995-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.